Genscript Biotech SEC Filings

Type
Report
Date
No documents available

Genscript Biotech Documents 2026

This page contains all official documents and SEC filings for Genscript Biotech stock (1548.HK, ISIN: KYG3825B1059). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Genscript Biotech's regulatory filings.

Genscript Biotech Stock analysis

Genscript Biotech GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide.